"We are a highly specialized medical office dedicated to improving healthcare by researching new treatments through clinical trials. Getting started in a clinical trial is easy as 1-2-3! Make an appointment to see if you qualify. 30 minutes at our office and you’ll know. Then, you decide if you want to enroll. Benefits of participating: No insurance needed Same day appointments available Access to cutting edge medication and treatment Compensation for time and travel Be a medical hero"

During the past decade, Clinical Neuroscience Solutions, Inc. conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 84 clinical trials were completed, i.e. on average, 82.4% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 53 clinical trials were completed. i.e. 117.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 sponsor was "Pfizer" with 21 trials, followed by "Shire" with 20 trials sponsored, "Sunovion" with 9 trials sponsored, "Allergan" with 8 trials sponsored and "Supernus Pharmaceuticals, Inc." with 8 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 collaborator was "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Neuroscience Solutions, Inc." are "Major Depressive Disorder" (18 trials), "ADHD" (14 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (9 trials), "Migraine" (7 trials) and "Atopic Dermatitis" (6 trials). Many other conditions were trialed in "Clinical Neuroscience Solutions, Inc." in a lesser frequency.

Most popular intervention types in "Clinical Neuroscience Solutions, Inc." are "Drug" (148 trials), "Other" (12 trials), "Biological" (10 trials), "Device" (2 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (80 trials), "placebo" (6 trials), "Atogepant" (4 trials), "Escitalopram" (4 trials) and "Lurasidone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Neuroscience Solutions, Inc." are 151 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Neuroscience Solutions, Inc.". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 123 completed trials in Clinical Neuroscience Solutions, Inc., undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Neuroscience Solutions, Inc., 2 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 99 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".